APA (7th ed.) Citation

Weisel, K., Mai, E. K., Seckinger, A., Kunz, C., Benner, A., Hose, D., . . . Goldschmidt, H. (2019). Addition of cyclophosphamide on insufficient response to pomalidomide and dexamethasone: Results of the phase II PERSPECTIVE multiple myeloma trial. Blood cancer journal, 9(4), . https://doi.org/10.1038/s41408-019-0206-8

Chicago Style (17th ed.) Citation

Weisel, Katja, Elias K. Mai, Anja Seckinger, Christina Kunz, Axel Benner, Dirk Hose, Anna Jauch, and Hartmut Goldschmidt. "Addition of Cyclophosphamide on Insufficient Response to Pomalidomide and Dexamethasone: Results of the Phase II PERSPECTIVE Multiple Myeloma Trial." Blood Cancer Journal 9, no. 4 (2019). https://doi.org/10.1038/s41408-019-0206-8.

MLA (9th ed.) Citation

Weisel, Katja, et al. "Addition of Cyclophosphamide on Insufficient Response to Pomalidomide and Dexamethasone: Results of the Phase II PERSPECTIVE Multiple Myeloma Trial." Blood Cancer Journal, vol. 9, no. 4, 2019, https://doi.org/10.1038/s41408-019-0206-8.